Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide.

Cancer Chemother Pharmacol · 2014 · PMC4143677 · PMID 25053385

Europe PMC DOI

hedged sentence

0.1600

closest p · 3.2× alpha

0.1600

boldest claim

The sentences

a negative trendp = 0.16not close (p > 0.1)

Relation between measured OzVal-Hb adduct level and hematologic variables In dose group B, a negative trend was observed between OzVal-Hb adduct measured after the first dose and relative decrease of WBC (Rs = −0.66, p = 0.16, n = 6) and neutrophils (Rs = −0.46, p = 0.35, n = 6) measured day 8 after treatments and Hb levels after dose cycle three versus baseline values (Rs = −0.83, p = 0.04, n = 6).

also in 4,201 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.